PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,478 | -41.6% | 4,082 | +6.0% | 0.01% | -37.5% |
| Q2 2023 | $156,620 | -14.2% | 3,851 | +2.2% | 0.01% | -11.1% |
| Q1 2023 | $182,570 | +10.2% | 3,769 | -13.2% | 0.01% | +28.6% |
| Q4 2022 | $165,696 | -22.2% | 4,341 | +2.4% | 0.01% | -30.0% |
| Q3 2022 | $212,848 | +25.3% | 4,240 | 0.0% | 0.01% | +42.9% |
| Q2 2022 | $169,854 | +0.8% | 4,240 | -6.2% | 0.01% | +16.7% |
| Q1 2022 | $168,567 | -76.4% | 4,518 | -74.9% | 0.01% | -40.0% |
| Q4 2021 | $715,586 | +0.5% | 17,966 | -6.1% | 0.01% | 0.0% |
| Q3 2021 | $712,088 | -12.0% | 19,137 | +0.0% | 0.01% | -9.1% |
| Q2 2021 | $808,794 | +1.9% | 19,134 | +14.2% | 0.01% | -8.3% |
| Q1 2021 | $793,349 | -26.0% | 16,755 | -4.6% | 0.01% | -25.0% |
| Q4 2020 | $1,071,870 | +25.3% | 17,563 | -4.0% | 0.02% | +6.7% |
| Q3 2020 | $855,665 | -9.2% | 18,303 | -1.5% | 0.02% | -11.8% |
| Q2 2020 | $942,394 | +13.7% | 18,573 | 0.0% | 0.02% | -5.6% |
| Q1 2020 | $828,542 | -6.1% | 18,573 | +1.1% | 0.02% | +20.0% |
| Q4 2019 | $881,975 | +39.8% | 18,363 | -1.6% | 0.02% | +36.4% |
| Q3 2019 | $631,047 | -17.5% | 18,659 | +9.7% | 0.01% | -15.4% |
| Q2 2019 | $765,270 | +23.1% | 17,006 | +3.0% | 0.01% | +18.2% |
| Q1 2019 | $621,436 | +19.3% | 16,510 | +8.7% | 0.01% | +10.0% |
| Q4 2018 | $521,081 | -24.9% | 15,183 | +2.8% | 0.01% | -16.7% |
| Q3 2018 | $694,143 | -99.9% | 14,769 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $498,158,000 | +41.4% | 14,769 | +13.5% | 0.01% | +60.0% |
| Q1 2018 | $352,213,000 | +162210.1% | 13,016 | 0.0% | 0.01% | +66.7% |
| Q4 2017 | $217,000 | -60.4% | 13,016 | -52.5% | 0.00% | 0.0% |
| Q3 2017 | $548,000 | +27.1% | 27,393 | +16.4% | 0.00% | 0.0% |
| Q2 2017 | $431,000 | +85.8% | 23,530 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $232,000 | -9.7% | 23,530 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $257,000 | -8.5% | 23,530 | +17.4% | 0.00% | 0.0% |
| Q3 2016 | $281,000 | +69.3% | 20,037 | -15.5% | 0.00% | +100.0% |
| Q2 2016 | $166,000 | +8.5% | 23,703 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $153,000 | -80.1% | 23,703 | 0.0% | 0.00% | -83.3% |
| Q4 2015 | $768,000 | +21.3% | 23,703 | 0.0% | 0.01% | +20.0% |
| Q3 2015 | $633,000 | -44.5% | 23,703 | 0.0% | 0.01% | -37.5% |
| Q2 2015 | $1,141,000 | -0.8% | 23,703 | +25.4% | 0.01% | 0.0% |
| Q1 2015 | $1,150,000 | -81.7% | 18,904 | -84.5% | 0.01% | -81.8% |
| Q4 2014 | $6,298,000 | +19.0% | 121,650 | +1.2% | 0.04% | +15.8% |
| Q3 2014 | $5,292,000 | +1055.5% | 120,253 | +586.9% | 0.04% | +1166.7% |
| Q2 2014 | $458,000 | +59.0% | 17,507 | +59.1% | 0.00% | +50.0% |
| Q1 2014 | $288,000 | +54.0% | 11,005 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $187,000 | -20.8% | 11,005 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $236,000 | – | 11,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |